4.05 Exodus from Academia and the Regretful FDA Approval of Aducanumab with Dr. Ameet Sarpatwari - a podcast by Vinay Prasad, MD MPH

Today we are joined by Dr. Ameet Sarpatwari of Harvard Medical School to discuss how so many great minds in oncology are leaving cancer research in academia for industry. We also talk about the evidence (or lack thereof) behind the recent FDA approval of aducanumab to treat Alzheimer's disease.

Back us on Patreon! www.patreon.com/plenarysessionCheck out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Further episodes of Plenary Session

Further podcasts by Vinay Prasad, MD MPH

Website of Vinay Prasad, MD MPH